Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis

被引:12
|
作者
Moroni, Gabriella [1 ,2 ]
Porata, Giulia [3 ]
Raffiotta, Francesca [4 ]
Frontini, Giulia [5 ]
Calatroni, Marta [1 ,2 ]
Reggiani, Francesco [1 ,2 ]
Banfi, Giovanni [6 ]
Ponticelli, Claudio [7 ]
机构
[1] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Nephrol & Dialysis Div, Rozzano, Italy
[3] ASST Santi Paolo & Carlo, UO Nefrol & Dialisi, Milan, Italy
[4] ASST Fatebenefratelli Sacco, UO Nefrol & Dialisi, Milan, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nefrol Dialisi & Trapianto Rene, Milan, Italy
[6] St Agostino Med Ctr, Milan, Italy
[7] Nephrol, Milan, Italy
来源
LUPUS SCIENCE & MEDICINE | 2022年 / 9卷 / 01期
关键词
RENAL OUTCOMES; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; CLASSIFICATION; AZATHIOPRINE; INFLAMMATION; TRIAL;
D O I
10.1136/lupus-2022-000721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Based on available data, the histological predictors of long-term outcome of lupus nephritis (LN) are not clearly defined. Aims of this retrospective study were: (i) to evaluate the change of chronicity index from the first to second kidney biopsy and to find the predictors of chronicity index increase and (ii) to detect the clinical/ histological features at first and at second kidney biopsy associated with long-term kidney function impairment. Methods Among 203 biopsy proven LN subjects, 61 repeated kidney biopsy 49 months after the first biopsy. The reasons for repeated biopsy were: nephritic flares in 25 (41%), proteinuric flares in 21 (36%) of patients and protocol biopsy in 14 (23%) of cases. Results During 23-year follow-up, 25 patients presented a decrease in glomerular filtration rate (eGFR) >= 30%. At repeat biopsy, chronicity index increased in 44 participants (72%) and did not increase in 17 (28%). Nephritic syndrome and serum creatinine >1.6 mg/dL at presentation correlated with chronicity index increase (p=0.031, 0.027, respectively), cyclophosphamide therapy tended to protect against chronicity index increase (p=0.059). Kidney flares occurred in 53.6% of patients with vs 23.5% of those without chronicity index increase (p=0.035). Chronicity index increases of 3.5 points in patients with kidney flares vs 2 in those without flares (p=0.001). At second, but not at first kidney biopsy, two different models predicted eGFR decrease at multivariate analysis. The first included activity index >3 (OR: 3.230; p=0.013) and chronicity index >4 (OR: 2.905; p=0.010), and the second model included moderate/severe cellular/fibrocellular crescents (OR: 4.207; p=0.010) and interstitial fibrosis (OR: 2.525; p=0.025). Conclusion At second biopsy, chronicity index increased in 3/4 of participants. Its increase was predicted by kidney dysfunction at presentation and occurrence of LN flares. Kidney function impairment was predicted by both activity and chronicity index and by some of their components at repeated biopsy, but not at first biopsy.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] LUPUS NEPHRITIS: IS THE KIDNEY BIOPSY CURRENTLY NECESSARY IN THE MANAGEMENT OF LUPUS NEPHRITIS?
    Issayeva, B.
    Aseeva, E.
    Nikishina, N.
    Mesnyankina, A.
    Solovyev, S.
    Issayeva, S.
    Saparbayeva, M.
    Amanzholova, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1513 - 1513
  • [22] Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
    Parodis, Ioannis
    Tamirou, Farah
    Houssiau, Frederic A.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2022, 70 (01)
  • [23] Histologic Predictors of Response and Prognosis in Lupus Nephritis: Why Segmental Sclerosis Should Not Be Part of the Chronicity Index
    Tinajero Sanchez, Denisse Nayely
    Zuniga Gonzalez, Erick Yasar
    Hernandez Andrade, Adriana
    Navarro Sanchez, Valeria
    Nordmann-Gomes, Alberto
    Zavala Miranda, Maria Fernanda
    Uribe-Uribe, Norma O.
    Mejia-Vilet, Juan M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
    Ioannis Parodis
    Farah Tamirou
    Frédéric A. Houssiau
    Archivum Immunologiae et Therapiae Experimentalis, 2022, 70
  • [25] Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients
    Wantanasiri, P.
    Satirapoj, B.
    Charoenpitakchai, M.
    Aramwit, P.
    LUPUS, 2015, 24 (08) : 835 - 845
  • [26] The clinical relevance of a repeat biopsy in lupus nephritis flares
    Daleboudt, Gabrielle M. N.
    Bajema, Ingeborg M.
    Goemaere, Natascha N. T.
    van Laar, Jaap M.
    Bruijn, Jan A.
    Berger, Stefan P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (12) : 3712 - 3717
  • [27] The Value of Repeat Biopsy in the Management of Lupus Nephritis Flares
    Narvaez, Javier
    Ricse, Milagros
    Goma, Montserrat
    Mitjavila, Francesca
    Fulladosa, Xavier
    Capdevila, Olga
    Torras, Joan
    Juanola, Xavier
    Pujol, Ramon
    Miquel Nolla, Joan
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [28] THE VALUE OF REPEAT RENAL BIOPSY IN THE MANAGEMENT OF LUPUS NEPHRITIS
    Alba, P.
    Karim, M. Y.
    Cuadrado, M. J.
    Bento, L.
    Abbs, I. C.
    Tungekar, M. F.
    D'Cruz, D. P.
    Khamashta, M. A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2002, 41 : 106 - 106
  • [29] Predictors of Future Repeat Renal Biopsies in Patients with Lupus Nephritis and Influence of Repeat Biopsy in Flare Management: A Retrospective Study
    Santana-Flores, Rosalba
    Ramu, Anitha
    Rajevac, Hana
    Jim, Belinda
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] The role of the kidney biopsy in the treatment of lupus nephritis
    Kashgarian, M
    RENAL FAILURE, 1996, 18 (05) : 765 - 773